In a previous study on canine vascular tumors, VEGFR-3 expression was found in the majority of hemagiosarcomas investigated, suggesting that this marker would not be suitable for the immunohistochemical discrimination between malignant and benign vascular tumors [26,27,28]. This evidence concerns the gene FLT4 and neoplasm.